Ligand Pharmaceuticals

-$1.99 (-1.79%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO
John L. Higgins
Employees
155
Headquarters
San Diego, California
Founded
1987

LGND Key Statistics

Market Cap
1.94B
Price-Earnings Ratio
40.11
Dividend Yield
—
Average Volume
135.41K
High Today
$111.85
Low Today
$109.06
Open Price
$110.47
Volume
123.10K
52 Week High
$219.75
52 Week Low
$78.26

LGND Earnings

$0.61
$0.95
$1.29
$1.63
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$1.34 per share
Actual
$1.63 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure